The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2018.
Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most popular fund investment industries, there are Therapeutics, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Feldan Therapeutics.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the GC, startups are often financed by Groupe Roski. The meaningful sponsors for the fund in investment in the same round are Stonebridge Ventures, Asahi Kasei Corporate Venture Capital, Anges Quu00e9bec Capital. In the next rounds fund is usually obtained by National Institutes of Health.
Related Funds
| Fund Name | Location |
| Finch Finance | 's-gravenhage, The Netherlands, Zuid-Holland |
| Junzi Capital Engineering | California, Sacramento, United States |
| Koc Holding | Istanbul, Istanbul, Turkey |
| Linde | Bridgewater, New Jersey, United States |
| Potomac Energy Fund | Frederick, Maryland, United States |
| Reach Capital | California, San Francisco, United States |
| Shanghai Pudong Science and Technology Investment | - |
| Source of Qianhe Capital | Beijing, Beijing, China |
| Underscore VC | Boston, Massachusetts, United States |
| Wipro Ventures | California, Mountain View, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Feldan Therapeutics | $13M | 18 Sep 2018 | Quebec |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Feldan Therapeutics | $13M | 18 Sep 2018 | Quebec |
